TipRanks
Go Ultimate55% OFF

ETFs with Innate Pharma (IPHA) Exposure

The following ETFs maintain exposure to Innate Pharma (IPHA). ETF holdings data are updated once a day, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.

1 ETFs Hold Innate Pharma (IPHA)

ETFs holding IPHA
SymbolETF NameAUMExpense Ratio% Weight in ETFMarket Value% Weight in IPHA
CHNA―――1.06%$39.61K0.02%
Find ETFs with the TipRanks ETF screener

Popular ETFs

Popular ETFs
CompanyPrice & ChangeFollow
SPYSPDR S&P 500 ETF Trust―
QQQInvesco QQQ Trust―
DIASPDR Dow Jones Industrial Average ETF Trust―
IWMiShares Russell 2000 ETF―
VOOVanguard S&P 500 ETF―

IPHA ETF Exposure FAQ

What ETFs hold Innate Pharma stock?
Innate Pharma (IPHA) is currently held by 1 ETF in TipRanks’ ETF exposure database. The ETF(s) with exposure to IPHA include CHNA.
Which ETF has the largest exposure to IPHA?
The ETF with the largest exposure to IPHA is CHNA, with approximately $39.61K in market value exposure.
How much IPHA stock is held by ETFs?
ETFs currently hold approximately $39.61K worth of Innate Pharma (IPHA) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.